Skip to content

TWO SIGMA INVESTMENTS, LP: CSAN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of TWO SIGMA INVESTMENTS, LP on CSAN, newest first. How the timeline and the estimate are built.

TWO SIGMA INVESTMENTS, LP held 113,942 CSAN shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 113,942 shares
    Change vs previous 13F -388,112 shares

    <0.01% of the 13F portfolio, value $328,153.

    13F-HR 0000899140-26-000855 filed by TWO SIGMA INVESTMENTS, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 502,054 shares
    Change vs previous 13F +502,054 shares

    <0.01% of the 13F portfolio, value $2,068,462.

    13F-HR 0000899140-26-000547 filed by TWO SIGMA INVESTMENTS, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -20,049 shares

    13F-HR 0000899140-25-001286 filed by TWO SIGMA INVESTMENTS, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2025-06-30
    13F 20,049 shares
    Change vs previous 13F -2,600 shares

    <0.01% of the 13F portfolio, value $101,247.

    13F-HR 0000899140-25-000964 filed by TWO SIGMA INVESTMENTS, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-03-31
    13F 22,649 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $118,228.

    13F-HR 0000899140-25-000680 filed by TWO SIGMA INVESTMENTS, LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).